Results 251 to 260 of about 119,169 (307)

Blood expression of CTLA-4, PD-1, and PD-L1 as potential prognostic and diagnostic markers for breast cancer: a systematic review. [PDF]

Discov Oncol
Niusha M, Hajazimian S, Soltani N, Goleij P, Pagard P, Oruji F, Behroozi J, Shabani S, Isazadeh A, Baradaran B.   +9 more
europepmc   +1 more source

Incidence of pneumonitis with CTLA-4 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Li W, Xiong H, Peng H, Yang T, Fan L, Zhang Y.   +5 more
europepmc   +1 more source

Engineered ipilimumab variants that bind human and mouse CTLA-4. [PDF]

MAbs
Robison B, Diong SJ, Kumar A, Moon TM, Chang O, Chau B, Bee C, Barman I, Rajpal A, Korman AJ, West S, Strop P, Lee PS.   +12 more
europepmc   +1 more source

Oral lichenoid lesions in CTLA‐4 haploinsufficiency: Targeting IFN‐γ‐driven mucosal immunopathology

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Chen Wang, Laurie Brenchley, Teresa Greenwell‐Wild, Vasileios Ionas Theofilou, Timothy G. Myers, Chi A. Ma, Katherine Howe, Stefania Pittaluga, Steven M. Holland, Niki M. Moutsopoulos, David Fraser, Gulbu Uzel   +11 more
wiley   +1 more source

Anti-CTLA-4 Treatment Abrogates Co-stimulation Blockade-induced Acceptance of Transgenic Porcine Islets in Humanized Mice. [PDF]

Transplantation
Seissler J, Figueiredo C, Kemter E, Klymiuk N, Wolf E, Wolf-van Buerck L.   +5 more
europepmc   +1 more source

PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC. [PDF]

J Immunother Cancer
Miyakoshi J, Yoshida T, Uehara Y, Takeyasu Y, Shirasawa M, Fukuda A, Kashima J, Kumagai S, Horinouchi H, Ono H, Shiraishi K, Kohno T, Kondo S, Goto Y, Yamamoto N, Yatabe Y, Hosomi Y, Kurata T, Naoki K, Suzuki T, Ohe Y.   +20 more
europepmc   +1 more source

Polimorfizm genu CTLA-4 w łuszczycy zwykłej = CTLA-4 gene polymorphism in psoriasis vulgaris

Przegląd Dermatologiczny, 2004
Łuszczek, W., Jasek, M., Wiśniewski, A., Kuśnierczyk, P.   +3 more
openaire  

Some of the next articles are maybe not open access.

Related searches:

CTLA-4 upregulation during aging

Mechanisms of Ageing and Development, 2002
The immune system gradually becomes anergic with age. Here, we measured intracellular levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), a negative regulator of T-cells, in 53 healthy individuals aged 18-94.
Qibin, Leng, Zvi, Bentwich, Gadi, Borkow
openaire   +2 more sources